Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True

Immunotherapy is increasingly used in the treatment of multiple myeloma (MM). Monoclonal antibodies (mAbs) are safe and effective ways to elicit immunotherapeutic responses. In 2015, daratumumab has become the first mAb approved by the Food and Drug Administration for clinical use in MM and, in the...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Agostino, Mattia, Innorcia, Salvatore, Boccadoro, Mario, Bringhen, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662679/
https://www.ncbi.nlm.nih.gov/pubmed/33139668
http://dx.doi.org/10.3390/ijms21218192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662679/
https://www.ncbi.nlm.nih.gov/pubmed/33139668
http://dx.doi.org/10.3390/ijms21218192

Ejemplares similares